Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the first implant of PARADYM RF in Canada at the Montreal Heart Institute. The PARADYMTM RF family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT-D) devices is fully supported by the recently launched SMARTVIEWTM remote monitoring system.
Researchers have found that using telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that do not have an around-the-clock neurologist, or stroke expert, on staff. The research, published today in Circulation: Cardiovascular Quality and Outcomes, is intended to help hospital administrators evaluate telestroke.
Restoration Robotics, Inc. today announced the first use of its revolutionary ARTAS® System in Minneapolis by Dr. Ron Shapiro of Shapiro Medical Group. The ARTAS System – the first and only FDA cleared physician controlled, computer-assisted technology for harvesting follicular units directly from the scalp – offers hair restoration physicians and patients unprecedented levels of safety, efficacy, and patient comfort.
Health Robotics today reported a new i.v.STATION "Go Live" in record time at Wyoming Medical Center in Casper, Wyoming. This quick implementation highlights the benefits that Health-System Pharmacies can immediately garner from Health Robotics' streamlined implementation processes, especially in light of the recent drug shortages and closures of NECC and Ameridose.
RIVA, the fully automated IV compounding system manufactured by Intelligent Hospital Systems (IH Systems), is ahead of competitors in overall performance, meeting business case expectations and customer satisfaction, according to a new study of IV automation systems by independent healthcare research firm KLAS.
The world’s first implantable robotic arm controlled by thoughts is being developed by Chalmers researcher Max Ortiz Catalan. The first operations on patients will take place this winter.
The radiotherapy is delivered by a non-invasive robotic device called IRay® Radiotherapy System which uses low-level radiation, similar to a dental x-ray. Patients treated with the IRay device sit at the machine with their chin on a chin rest.
An Indiana University study in the Journal of Child Neurology proposes an innovative treatment for developmental coordination disorder, a potentially debilitating neurological disorder in which the development of a child's fine or gross motor skills, or both, is impaired.
Hansen Medical, Inc, a global leader in intravascular robotics, today announced that President and CEO, Bruce Barclay, is scheduled to present at the 24th Annual Piper Jaffray Healthcare Conference. The conference is being held November 27-28, 2012, at the New York Palace Hotel, in New York, NY. Hansen Medical is scheduled to present on Wednesday, November 28, 2012 at 2:30 p.m. Eastern Time.
Health Robotics today disclosed its ASHP Mid-Year plans to emphasize its superior solutions for Health-Systems to deal with the recent industry problems due to outsourced sterile compounding company closures, shortages and safety risks, together with its unparalleled advances in Oncology Sterile Compounding at the American Society of Health System Pharmacists (ASHP) Midyear Meeting & Exhibition, to be held in Las Vegas on 2-5 December 2012 (Booth 853).
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.